The Critical Gap in Cannabis Evidence for Mental Health Conditions
The sparse evidence cannabis mental health research reveals highlights a significant gap in clinical knowledge. Clinicians currently lack sufficient data to guide psychiatric therapy involving cannabis. This gap underscores the urgent need for rigorous…
CED Digest: 230 Items — March 18, 2026
Cannabis compounds CBD and CBG fatty liver benefits are gaining attention for their potential to reduce hepatic steatosis. These cannabinoids show promise in improving metabolic health markers. Clinicians should consider emerging evidence on cannabis…
In the Mix: 9 More Articles — March 18, 2026
This article highlights a cannabinoid study depression anxiety PTSD research relevant to cannabis clinical practice. It compares cannabinoids with other treatments for mood disorders. The findings provide insights into therapeutic potential and safety…
No ‘Next Day’ Impairment Caused by Cannabis – The Leaf Online
Recent research on no next day cannabis impairment offers new clinical insights. This focus keyword highlights findings about cannabis timing and safety. Understanding cannabis effects on daytime function is crucial for patient counseling.
Avicanna Sponsors University of Calgary’s ‘Sensitive Dosing Window’ Medical THC Study
The sensitive dosing window medical THC study provides crucial evidence-based guidance for clinicians prescribing medical cannabis. This University of Calgary research identifies effective THC dosing ranges that improve patient outcomes. Findings support…
Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
This study examines cannabis effectiveness mental health and finds limited proof supporting its use for most psychiatric conditions. Despite patient interest, clinical evidence remains insufficient. Clinicians should prioritize evidence-based treatments…
Cannabis useless for treating mental health issues – Australian review – Juta MedicalBrief
The Australian review highlights cannabis mental health clinical evidence as insufficient for treating depression, anxiety, and psychosis. This challenges common patient beliefs about cannabis benefits for psychiatric conditions. Clinicians should guide…
Large Medical Cannabis Review Finds Scarce Evidence It Treats Mental Health Disorders
A large review finds scarce evidence supporting cannabis mental health disorders efficacy. Clinicians face uncertainty due to limited data on cannabis mental health disorders efficacy and safety. Patients should be counseled on established treatments…
Teenage Cannabis Use Linked to 52% Higher Schizophrenia Risk – Neuroscience News
Teenage cannabis psychosis risk is significantly elevated, with studies showing a 52% higher chance of developing schizophrenia. Adolescent cannabis use impacts brain development uniquely compared to adults. Clinicians should prioritize screening and…
Scientists find no convincing evidence of cannabis effectiveness for mental health: review
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthResearchSafety Why This Matters Clinicians should be aware that despite patient interest and anecdotal…